Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,217

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

Open access
Yatham, Lakshmi N, Kennedy, Sidney H, Parikh, Sagar V, Schaffer, Ayal, Beaulieu, Serge, Alda, Martin, O’Donovan, Claire, MacQueen, Glenda, McIntyre, Roger S, Sharma, Verinder, Ravindran, Arun, Young, L Trevor, Milev, Roumen, Bond, David J, Frey, Benicio N, Goldstein, Benjamin I, Lafer, Beny, Birmaher, Boris, Ha, Kyooseob, Nolen, Willem A, Berk, Michael·2013·Bipolar Disorders
DOI 10.1111/bdi.12025
Open this paper in CoChat — free account

Abstract

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd. The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bdi.12025

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 97 references

Research works printed but not linked: 326

  1. 10.1111/j.1399-5618.2009.00672.x · DOI · Paper page
  2. 10.1177/070674370905401103 · DOI
  3. 10.1111/j.1399-5618.2009.00786.x · DOI · Paper page
  4. 10.1016/j.jad.2011.04.036 · DOI
  5. Stensland MD, 2010, Costs associated with attempted suicide among individuals with bipolar disorder, J Ment Health Policy Econ, 13, 87
  6. 10.1016/j.eurpsy.2010.01.001 · DOI
  7. 10.4088/JCP.7075su1c.02 · DOI
  8. 10.1111/j.1399-5618.2010.00856.x · DOI
  9. 10.4088/JCP.10m06618 · doi:10.4088/jcp.10m06618
  10. 10.1186/1471-244X-9-33 · DOI
  11. 10.1177/070674370905400208 · DOI
  12. 10.1001/archgenpsychiatry.2010.15 · DOI
  13. 10.1111/j.1399-5618.2007.00556.x · DOI
  14. American Psychiatric Association, 2011, DSM‐5 Development: Bipolar and Related Disorders
  15. 10.1192/bjp.bp.109.065524 · DOI
  16. 10.1176/appi.ajp.2009.09030342 · DOI
  17. 10.1016/j.jad.2011.04.026 · DOI
  18. 10.1111/j.1399-5618.2010.00852.x · DOI
  19. 10.1080/00048670902873722 · DOI · Paper page
  20. 10.3109/09638237.2010.525565 · DOI
  21. 10.1097/00004850-199705000-00009 · DOI
  22. 10.4088/JCP.v65n0315 · DOI
  23. 10.1016/j.pnpbp.2007.09.007 · DOI
  24. Feifel D, 2011, A naturalistic, single‐blind comparison of rapid dose administration of divalproex ER versus quetiapine in patients with acute bipolar mania, Innov Clin Neurosci, 8, 29
  25. 10.1097/00004714-200108000-00006 · DOI · Paper page
  26. 10.1002/hup.870 · doi:10.1002/hup.870
  27. 10.1111/j.1742-1241.2009.02116.x · doi:10.1111/j.1742-1241.2009.02116.x
  28. 10.1590/S1516-44462011000100008 · DOI
  29. 10.4088/JCP.v62n0104 · DOI · Paper page
  30. 10.1007/s002130000658 · DOI · Paper page
  31. 10.4088/JCP.v61n1208 · doi:10.4088/jcp.v61n1208
  32. 10.1097/JCP.0b13e318033bd5e · DOI
  33. 10.1002/j.1875-9114.1998.tb03827.x · DOI
  34. Chouinard G, 1993, A double‐blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms, Can J Psychiatry, 38, S114
  35. 10.1177/0091270009347870 · doi:10.1177/0091270009347870
  36. 10.1016/S0140-6736(11)60873-8 · DOI · Paper page
  37. 10.1017/S1461145709991246 · DOI
  38. 10.1097/YIC.0b013e3282fd827c · DOI
  39. 10.1097/YIC.0b013e328333ac1b · DOI
  40. 10.4088/JCP.v67n1003 · DOI
  41. 10.4088/JCP.08m04960yel · DOI
  42. 10.1192/bjp.bp.108.049965 · DOI
  43. 10.1177/0269881108099418 · DOI
  44. 10.1111/j.1399-5618.2010.00815.x · DOI
  45. 10.1016/j.jad.2010.06.030 · DOI
  46. 10.1111/j.1399-5618.2009.00748.x · DOI · Paper page
  47. 10.1016/j.jad.2009.12.028 · DOI · Paper page
  48. 10.1111/j.1399-5618.2009.00749.x · DOI
  49. 10.1016/j.jad.2010.04.005 · DOI
  50. 10.1176/appi.ajp.2008.07101560 · DOI · Paper page
  51. 10.1185/03007991003779380 · DOI
  52. 10.1016/S0924-9338(10)71430-9 · doi:10.1016/s0924-9338(10)71430-9
  53. El‐Mallakh RS, 2010, A blinded, randomized comparison of immediate‐release and extended‐release carbamazepine capsules in manic and depressed bipolar subjects, Ann Clin Psychiatry, 22, 3
  54. 10.1097/YIC.0b013e328329b199 · doi:10.1097/yic.0b013e328329b199
  55. 10.1016/j.eurpsy.2008.12.014 · DOI
  56. 10.1016/j.pnpbp.2008.10.012 · DOI
  57. Knesevich M, 2009, The Efficacy and Tolerability of Cariprazine in Acute Mania Associated With Bipolar I Disorder: A Phase II Trial [Abstract NR1‐049]
  58. 10.1111/j.1440-1819.2010.02066.x · DOI
  59. 10.1111/j.1399-5618.2006.00363.x · DOI
  60. 10.4088/JCP.v69n0806 · DOI
  61. 10.1016/j.jad.2010.08.015 · DOI
  62. 10.1111/j.1600-0447.2009.01368.x · DOI
  63. 10.1097/WNF.0b013e318184fae2 · DOI
  64. 10.1016/j.jad.2010.09.011 · DOI
  65. Pfizer Inc, 2010, 3‐Week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
  66. 10.1186/1744-859X-8-27 · DOI
  67. 10.4088/JCP.08m04895yel · DOI
  68. 10.1016/j.jpsychires.2010.05.016 · DOI
  69. 10.1186/1471-244X-11-101 · DOI
  70. 10.1097/JCP.0b013e3181f15849 · DOI
  71. 10.1192/bjp.bp.107.048504 · DOI · Paper page
  72. 10.1016/j.jad.2010.10.026 · DOI
  73. Kemp DE, 2010, Predictive value of early improvement in bipolar depression trials: a post‐hoc pooled analysis of two 8‐week aripiprazole studies, Psychopharmacol Bull, 43, 5
  74. Ketter T, 2011, Presented at 164th Ann Mtg American Psychiatric Association
  75. 10.4088/JCP.v66n0710 · DOI · Paper page
  76. 10.1016/j.jad.2009.10.007 · DOI
  77. 10.1017/S1461145708009735 · DOI · Paper page
  78. 10.1016/j.jad.2009.10.033 · DOI
  79. Loebel A, 2012, Lurasidone Adjunctive to Lithium or Valproate for the Treatment of Bipolar I Depression: Results of a 6‐Week, Double‐Blind, Placebo‐Controlled
  80. 10.4088/JCP.08m04152 · DOI · Paper page
  81. 10.1111/j.1600-0447.2009.01537.x · DOI
  82. 10.1192/bjp.bp.112.108357 · DOI
  83. 10.1002/hup.1082 · DOI
  84. 10.1097/YCT.0b013e3181b00f1e · DOI
  85. 10.1016/j.jad.2010.05.008 · DOI
  86. 10.1111/j.1600-0447.2009.01493.x · DOI
  87. 10.1001/archgenpsychiatry.2010.90 · DOI · Paper page
  88. 10.4088/JCP.09m05900gry · DOI
  89. Pfizer Inc, 2009, A Six‐Week Study Evaluating the Efficacy and Safety of GEODON in Patients With a Diagnosis of Bipolar I Depression
  90. Pfizer Inc, 2009, A Six‐Week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression
  91. 10.4088/JCP.09m05934 · DOI · Paper page
  92. 10.1517/14656560802504490 · DOI
  93. 10.1016/j.jad.2008.01.004 · DOI
  94. 10.1002/hup.1096 · DOI
  95. 10.1016/j.psychres.2008.05.003 · DOI
  96. 10.4088/JCP.09m05659gre · DOI
  97. 10.1176/ps.2007.58.1.85 · DOI · Paper page
  98. 10.4088/JCP.v65n1218 · DOI
  99. 10.4088/JCP.09r05385gre · DOI · Paper page
  100. 10.1176/appi.ajp.158.6.906 · DOI · Paper page
  101. 10.1111/j.1440-1819.2010.02098.x · DOI
  102. 10.1176/appi.ajp.163.2.232 · DOI · Paper page
  103. 10.4088/JCP.v63n0607 · DOI · Paper page
  104. Devulapalli KK, 2010, Why do persons with bipolar disorder stop their medication?, Psychopharmacol Bull, 43, 5
  105. 10.1016/j.comppsych.2008.06.008 · DOI
  106. 10.1055/s-0030-1263169 · DOI
  107. 10.1016/j.eurpsy.2009.09.003 · DOI
  108. 10.3111/13696998.2011.562265 · DOI
  109. Bates JA, 2010, Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross‐sectional survey, PCC J Clin Psychiatry, 12, e1
  110. Gianfrancesco FD, 2009, Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder, Ann Clin Psychiatry, 21, 3
  111. 10.1016/j.schres.2009.09.023 · DOI
  112. 10.1016/j.jad.2010.05.021 · DOI
  113. 10.1186/1744-859X-8-7 · DOI
  114. 10.2146/ajhp080374 · DOI
  115. 10.3109/15622970903544638 · doi:10.3109/15622970903544638
  116. 10.1016/j.euroneuro.2010.08.001 · DOI
  117. Gao K, 2010, Predictors of non‐stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post‐hoc analysis of two studies, Psychopharmacol Bull, 43, 23
  118. 10.1111/j.1399-5618.2010.00826.x · DOI
  119. 10.1080/15433710903176088 · DOI
  120. 10.1001/archpsyc.60.2.145 · DOI · Paper page
  121. 10.1002/9780470661277.ch32 · DOI
  122. 10.1192/bjp.bp.107.040485 · DOI · Paper page
  123. 10.1192/bjp.bp.108.058263 · DOI
  124. 10.1016/j.jad.2009.03.018 · DOI
  125. 10.1177/0269881108093885 · DOI
  126. 10.1017/S1461145711000885 · DOI
  127. 10.1016/S0140-6736(09)61828-6 · DOI · Paper page
  128. 10.1111/j.1399-5618.2011.00887.x · DOI
  129. 10.1111/j.1399-5618.2010.00836.x · DOI
  130. 10.1177/0269881109106900 · DOI
  131. 10.1016/j.jad.2010.11.037 · DOI
  132. 10.1176/appi.ajp.2008.08020189 · DOI · Paper page
  133. 10.1111/j.1399-5618.2009.00761.x · DOI · Paper page
  134. 10.1080/15622970701530917 · DOI
  135. 10.1111/j.1399-5618.2011.00898.x · DOI
  136. Carlson B, 2010, Efficacy and Safety of Aripiprazole in Combination With Lamotrigine in a Long‐Term Maintenance Study in Manic or Mixed Subjects With Bipolar I Disorder (CN138‐392) [Abstract]
  137. 10.4088/JCP.09m05482yel · DOI · Paper page
  138. 10.1002/hup.990 · DOI
  139. 10.1097/JCP.0b013e3181ad223f · DOI
  140. 10.4088/JCP.08m04909gre · DOI
  141. 10.1016/j.jad.2008.11.003 · DOI
  142. 10.4088/JCP.08m04045 · DOI
  143. 10.1111/j.1440-1819.2009.02026.x · DOI
  144. 10.1176/appi.ajp.2010.09121816 · DOI · Paper page
  145. 10.1016/j.jad.2010.07.030 · DOI
  146. 10.1016/j.eurpsy.2009.11.010 · DOI
  147. 10.1016/S1701-2163(16)35082-4 · DOI
  148. Li X, 2009, Drug Utilization of Pregnancy Category D or X Drugs Among Child‐Bearing Age Women With Depression or Bipolar Disorder in Medicaid [Abstract]
  149. 10.1097/AOG.0b013e31816fd910 · DOI · Paper page
  150. 10.2165/00023210-200822040-00004 · DOI
  151. 10.1056/NEJMoa0907328 · DOI · Paper page
  152. 10.1016/j.yebeh.2009.09.024 · DOI
  153. 10.1136/bmj.c6581 · DOI · Paper page
  154. 10.1016/j.reprotox.2008.03.001 · DOI
  155. 10.1177/070674370905400405 · DOI · Paper page
  156. 10.1097/AOG.0b013e318220edcc · DOI · Paper page
  157. 10.1017/S0033291709992194 · DOI · Paper page
  158. 10.1111/j.1365-2125.2008.03261.x · DOI · Paper page
  159. 10.1002/bdra.20641 · DOI
  160. 10.1002/bdrb.20144 · DOI · Paper page
  161. 10.1007/s00737-008-0044-3 · DOI
  162. Food and Drug Administration, 2011, Antipsychotic Drugs: Class Labeling Change—Treatment During Pregnancy and Potential Risk to Newborns
  163. Imaz ML, 2011, Obstetrical and neonatal outcomes following prenatal exposure to lithium, Bipolar Disord, 13, 56
  164. 10.1007/s00737-010-0151-9 · DOI
  165. Chessick C, 2011, Sensitivity and specificity of the Mood Disorder Questionnaire in the perinatal population, Bipolar Disord, 13, 35
  166. 10.1111/j.1399-5618.2009.00685.x · DOI
  167. 10.1176/appi.ajp.2009.08121902 · DOI · Paper page
  168. 10.1007/s00737-010-0182-2 · DOI
  169. 10.1016/j.jad.2010.02.123 · DOI
  170. 10.1016/j.jpsychires.2008.11.003 · DOI
  171. 10.1097/01.chi.0000242240.69678.c4 · DOI · Paper page
  172. 10.1001/archpsyc.64.9.1032 · DOI · Paper page
  173. 10.4088/JCP.10m06290 · DOI · Paper page
  174. American Psychiatric Association, 2012, DSM‐5 Proposed Revision: Disruptive Mood Dysregulation Disorder
  175. 10.1001/archpediatrics.2011.832 · DOI
  176. 10.1111/j.1399-5618.2007.00563.x · DOI · Paper page
  177. 10.1176/appi.ajp.2009.08101569 · DOI · Paper page
  178. 10.1001/archpsyc.65.10.1125 · DOI · Paper page
  179. 10.1176/ajp.2007.164.4.582 · DOI · Paper page
  180. 10.1016/j.jad.2010.02.120 · DOI · Paper page
  181. 10.1176/appi.ps.60.8.1098 · doi:10.1176/appi.ps.60.8.1098
  182. 10.1111/j.1399-5618.2008.00659.x · DOI
  183. Evans‐Lacko SE, 2010, Evaluation of guideline‐concordant care for bipolar disorder among privately insured youth, Prim Care Companion J Clin Psychiatry, 12, e1
  184. 10.1111/j.1399-5618.2010.00791.x · DOI
  185. 10.1001/archgenpsychiatry.2012.650 · DOI · Paper page
  186. 10.1016/j.jad.2009.12.029 · DOI
  187. 10.4088/JCP.09m05845gre · DOI
  188. 10.1017/S0033291709991437 · DOI
  189. 10.4088/JCP.10m06025yel · DOI
  190. 10.4088/JCP.09m05585ora · DOI
  191. 10.4088/JCP.v69n1215 · DOI
  192. 10.1089/cap.2011.0009 · DOI
  193. 10.1001/archpsyc.65.9.1053 · DOI · Paper page
  194. 10.1111/j.1399-5618.2011.00890.x · DOI
  195. West AE, 2009, Child and family‐focused cognitive‐behavioral therapy for pediatric bipolar disorder: pilot study of group treatment format, J Can Acad Child Adolesc Psychiatry, 18, 239
  196. 10.1002/da.20668 · DOI
  197. 10.1097/CHI.0b013e3181ae0a08 · DOI · Paper page
  198. 10.1001/jama.2009.1152 · doi:10.1001/jama.2009.1152
  199. 10.1111/j.1399-5618.2009.00728.x · DOI · Paper page
  200. 10.1186/1471-244X-9-4 · DOI

200 of 326 shown

Cited by

See all 1,217

Metadata

Authors
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., Young, L. T., Milev, R., Bond, D. J., Frey, B. N., Goldstein, B. I., Lafer, B., Birmaher, B., Ha, K., Nolen, W. A., & Berk, M.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2012-12-12
Volume
15
Issue
1
Pages
1-44
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
DOI
10.1111/bdi.12025
OpenAlex
W1969114959
Cited by
1,217
References
97
FWCI
85.67
Type
journal article
Language
en
Open access
hybrid
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. https://app.cochat.ai/papers/10.1111/bdi.12025
The paper
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., Young, L. T., Milev, R., Bond, D. J., Frey, B. N., Goldstein, B. I., Lafer, B., Birmaher, B., Ha, K., . . . Berk, M. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders. https://doi.org/10.1111/bdi.12025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.